2017 Work Plan 

  • Medical Use of Cannabis and Health Effects
  • Letter request from House Courts of Justice Committee
  • Study whether CBD and THC-A oils have psychoactive/detrimental effects, and are they beneficial in treating: intractable epilepsy, cancer, glaucoma, human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C, amyotrophic lateral sclerosis, Crohn's disease, Alzheimer's disease, nail patella, cachexia or wasting syndrome, multiple sclerosis, or complex regional pain syndrome.
    • SJR 578 (Delegate Marshall), 2017
      • Study the long-term effects of marijuana use on individuals and populations. In conducting its study, the Joint Commission shall review scientific studies, including studies of individuals in states that have legalized or decriminalized the use of marijuana for medical or recreational purposes, and other sources to determine the long-term effects of marijuana use on individuals.
      • Should Medigap Policies be Provided for Medicare Recipients Under the Age of 65 Years in Virginia?
      • Letter request by Senator Wagner, 2017
      • Review issues related to providing access to Medigap policies by those who are disabled and under the age of 65 years. 
      • Creation of a Registry of Abuse or Neglect Cases for the Building Independence, Family and Individual Supports, and Community Living Waiver Programs in Virginia
      • HJ 675 (Delegate Landes), 2017
      • Study creation of a registry of cases of abuse or neglect of an individual receiving services through the Building Independence, Family and Individual Supports, or Community Living waiver program by a service provider to determine determine the scope of the proposed registry of cases of abuse or neglect; identify the statutory, regulatory, and policy changes that may be required; determine the cost of establishment and operation of such registry; and make such other recommendations to the establishment and operation of such registry as may be appropriate.
      • Prevalence and Risks of ADHD Medications in Virginia
      • HB 1500 Item 30A
      • Identify methods toraise awareness of risks related to the mental and physical health side effects of ADHD medication use and risk of drug addiction; compile and track statistics regarding the number of children in Virginia schools who are diagnosed with ADHD or other similar conditions; identify the incidence and prevalence of prescribing anti-psychotics for off-label use by general physicians and psychiatrists. 
      • Staffing Ratio Requirements for Assisted Living Facilities in Virginia
      • SJ 266 (Senator Dance), 2017
      • Identify and analyze current staff-to-resident ratio requirements for assisted living facilities and special care units and make recommendations for changes to such ratio requirements that would lead to better care and quality of life for residents, including recommendations regarding the total number and type of staff that  are required to meet the routine and special needs of all residents, must be awake and on duty during night shifts, and should accompany residents on trips away from the assisted living facility or special care unit.
      • Options for Increasing Use of Telemental Health Services in Virginia (2 Year Study)
      • HB 1500 Item 30B
      • Study options for increasing the use of telemental health services in the Commonwealth, including the issues and recommendations set forth in the report of the Telemental Health Work Group of the Joint Subcommittee Studying Mental Health Services in the Commonwealth in the 21st Century.
      • Sustainability of Virginia’s Prescription Monitoring Program
      • SJ 285 (Senator Carrico, Sr.), 2017
      • Study the sustainability of the Prescription Monitoring Program and identify potential funding sources for itsfuture operation. 
      • Heroin Use in Virginia
      • HJ 597 (Delegate Marshall), 2017
      • Study heroin use in the Commonwealth, including the rates of use, the pathways that lead individuals to use, and initiatives focused on the prevention of heroin use and heroin overdose, including the use of naloxone to prevent heroin overdoses.
    • Quality of Health Care Services in Virginia Jails and Prisons; and Impact of Requiring Community Service Boards to Provide Mental Health Services in Jails (2 Year Study)
      • Should Medical Aid-in-Dying be Legal in Virginia? (2 Year Study)
      • Letter of request from Delegate Kaye Kory, 2017
      • Review states that authorize medical aid-in-dying and answer the following questions:  What has been the impact of informing patients about end of-life options such as hospice care and palliative care?  How have the following acted to implement the law?  Health care providers;Health care systems;Health care institutions: Using data from states that allow medical aid-in-dying, how many people would likely utilize medical aid-in-dying if it became law in Virginia? Have people been coerced to ingest end-of-life medication? Have any of the states enacted protections to discourage or prevent coercion?